Prof. Dr. Dr. Oliver Friedrich

Lehrstuhl für Medizinische Biotechnologie (MBT)

Aging-related progressive skeletal muscle weakness in mutant DesR349P muscles: a matter of compromised cytoarchitecture (2016) Diermeier S, Buttgereit A, Clemen C, Schröder R, Friedrich O Journal article, other Hydroxyethyl starch solution for extracorporeal tissue perfusion (2016) Taeger C, Friedrich O, Drechsler C, Weigand A, Hobe F, Geppert CI, Münch F, et al. Journal article DesR349P Mutation Results in Ultrastructural Disruptions and Compromise of Skeletal Muscle Biomechanics Already at Preclinical Stages in Young Mice before the Onset of Protein Aggregation (2016) Diermeier S, Haug M, Reischl B, Buttgereit A, Schürmann S, Spörrer M, Goldmann W, et al. Conference contribution, Abstract of a poster Amyloidogenic amyloid-?-peptide variants induce microbial agglutination and exert antimicrobial activity (2016) Spitzer P, Condic M, Herrmann M, Oberstein T, Scharin-Mehlmann M, Gilbert D, Friedrich O, et al. Journal article Assessing viability of extracorporeal preserved muscle transplants using external field stimulation: a novel tool to improve methods prolonging bridge-to-transplantation time. (2015) Taeger C, Friedrich O, Dragu A, Weigand A, Hobe F, Drechsler C, Geppert CI, et al. Journal article, Original article Multiphoton microscopy analysis of extracellular collagen I network formation by mesenchymal stem cells. (2015) Vielreicher M, Gellner M, Rottensteiner U, Horch RE, Arkudas A, Friedrich O Journal article, Original article Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells. (2015) Menzner AK, Abolpour Mofrad S, Friedrich O, Gilbert D Journal article Septic cardiomyopathy in rat LPS-induced endotoxemia: relative contribution of cellular diastolic Ca2+ removal pathways, myofibrillar biomechanics properties and action of the cardiotonic drug levosimendan (2015) Wagner S, Schürmann S, Schüttler J, Hein S, Friedrich O Journal article, Original article S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction. (2015) Ritterhoff J, Völkers M, Seitz A, Spaich K, Gao E, Peppel K, Pleger S, et al. Journal article, Original article Vinculin phosphorylation at residues Y100 and Y1065 is required for cellular force transmission. (2015) Auernheimer V, Lautscham L, Leidenberger M, Friedrich O, Kappes B, Fabry B, Goldmann W Journal article, Original article